Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India’s CRDMO sector growth potential at $22 – $25 billion by 2035: Report
Report states that India’s CRDMO sector is poised for rapid growth with strong fundamentals and global realignments, focusing on…
Biocon Biologics launches YESINTEK, a Stelara biosimilar, in the United States
Biocon Biologics enters US market with YESINTEK, offering treatment options for Crohn’s disease, ulcerative colitis, plaque…
Venus Remedies partners with Infex Therapeutics for clinical development of MET-X in India
On an exclusive licensing agreement, Venus Remedies will lead clinical trials and commercialisation of MET-X to combat…
Cadila Pharmaceuticals expands warehouse to strengthen logistics and market reach
Cadila Pharmaceuticals expands its warehouse facility to enhance operational efficiency, streamline logistics, and support growing…
Amgen launches $200 million technology and innovation hub in Hyderabad
The new Amgen India site will enhance global digital capabilities through AI and data science, creating opportunities for local…
Dealsphere launches in India, streamlining nutraceutical licensing and commercialisation
Nutrify Today introduces instant commerce platform, reducing product development timelines for nutraceutical companies
From wellness to wealth: How Gen Y, Gen Z, and AI are driving mission $100 billion for India’s…
Vikas Bansi, Business Director- India OTC - Himalaya Wellness, Sailesh S, Partner, Anthill Ventures, Len Monheit, CEO, Industry…
Senores Pharmaceuticals acquires USFDA-approved Roflumilast ANDA from Breckenridge Pharmaceutical
Acquisition aligns with Senores’ strategy to expand into chronic bronchitis treatment and specialty distribution in the US market…
LANXESS inaugurates India Application Development Center
Supports innovation and tailored solutions for India’s industrial and consumer markets
Granules India acquires Senn Chemicals AG to expand peptide therapeutics and CDMO capabilities
Acquisition strengthens Granules’ entry into the peptide-based therapeutics market and enhances CDMO capabilities through Senn’s…